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Abstract 
Anaemia is common in preterm babies in the neonatal intensive care unit. The two 
most common causes are frequent blood sampling for laboratory studies in sick premature 
infants and the physiologic anaemia of prematurity. Anaemia has been shown to lead to 
myocardial dysfunction in adults (Cannella G et al., 1990). Its effect on circulation in 
preterm babies however has not been thoroughly evaluated. 
In order to maintain adequate oxygen supply, compensatory mechanisms may arise. 
The attempts to compensate for anaemia include the increase in heart rate and cardiac 
output, higher oxygen consumption and high oxygen extraction ratios and the increase in 
the production of erythropoietin. How blood transfusion would affect these compansatory 
mechanisms is not entirely clear. 
This study, which was divided into two parts, was set out to investigate the acute 
effects of red blood cell transfusion in preterm infants on the left ventricular output and the 
oxygen consumption. Premature babies who required red blood cell transfusion and 
fulfilled the following enrollment criteria were studied: 1) gestational age < 36 weeks, 2) 
postnatal age < 4 weeks, and 3) haematocrit < 40% in both parts of the study, and 4) 
weighing more than 1000 grams in the second part of the study. Left ventricular output was 
measured by Doppler and echocardiography in the first part of the study and oxygen 
consumption was measured by a Deltatrac metabolic monitor in the second part ofthe study 
one hour before the commencement of transfusion, and repeated one hour and 24 hours 
after the completion of transfusion. 
57 preterm babies were studied in the first study. Univariate analysis using paired 
t-test showed that cardiac index decreased by an average of 8.7% 24 hours after transfusion 
(p<0.05). Systemic red cell transport increased significantly 24 hours after transfusion 
(p<0.05). Multivariate analysis showed that cardiac index was negatively associated with 
haematocrit and the index was higher in male infants. 
10 preterm babies were studied in the second study. Paired t-test showed that heart 
rate decreased by an average of 7.78% 24 hours after transfusion. There were no significant 
changes in oxygen consumption, carbon dioxide production and respiratory rate one hour 
and 24 hours after transfusion. 
We conclude that there was a significant drop in cardiac index and an improvement 
in systemic red cell transport 24 hours after transfusion in premature babies. There was no 
significant change in oxygen consumption after red cell transfusion in our group of 
premature infants. This however could be due to the small case number included in the 
study. 
；商要 
在新生兒深切治療部裏，早產兒的貧血現象是很常見的。 
引致貧血的原因很多，其中最常見的兩個原因是1)頻密的抽取血 
樣本以進行化驗，及2)早產兒的生理性貧血。有硏究報告顯示 
對成人而言，貧血可引致心肌功能不全，但貧血對早產兒循環系 
統的影響仍未有人作徹底評估。 
爲了維持足夠的氧份供應，機體會產生一系列代償機制。 
新生兒對貧血所產生的代償機制可包括心率及心輸出的增加，耗氧 
量的改變，氧提取率(Oxygen extraction瓜1丨0)的提高，與及促紅細 
胞生成素 (Erythropoie t in)產生的增加。然而輸血對代償機制的影 
嚮，仍未完全淸楚了解。 
是項硏究計劃可分爲兩部份，去檢查輸血對在病房中的早 
產兒的1)左心輸出；2)耗氧量的急性影響。硏究計劃對須要輸 
血治療並且符合以下標準的早產兒進行檢測：1)孕週少於36週;2) 
出生後4週以內；3)紅細胞壓積(出6013100”10在40%以下及4)在 
第二部份實驗中，早產兒體重須大於1，000克。檢查於開始輸血 
前1小時，輸血後1小時及24小時進行。硏究的第一部份，以 
超聲心動圖量度左心輸出，而硏究的第二部份，以“06113&€，，代謝 
監測器量度機體的耗氧量。 
於第一部份硏究中，57名早產兒受測試。作單變量分析 
(Univariate &11乂乂313)中的成對t檢驗(?&&601 t-test)，顯示心輸出指數 
(Cardiac ^46乂)於輸血24小時後平均下降8.7% (P値<0.05)，系統 
性紅細胞運輸(8乂3160化red cell的03?010於輸血後24小時明顯增加 
(P ffi<0.05)�多變量分析(Multivariate &031乂8丨3)顯示心輸出指數與紅 
細胞壓積呈負性相關(Negative correlation) ’男性早產兒心輸出指數 
較女性爲高。 
第二部份硏究中，10名早產兒受測試。成對t檢驗示心率 
于輸血24小時后，平均下降7.78%(?値<0.05)。耗氧量，二氧化 
碳產生量，呼吸速率在輸血後均無明顯改變。 
我們的結論爲：輸血後24小時早產兒的心輸出有明顯下 
降，系統性紅細胞運輸亦有改善。我們實驗組中的早產兒在輸血 
後耗氧量沒有明顯變化，但這有可能是我們受檢之病例數太少所弓I 
致。 
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Section L Literature review 
1.1 Physiology of anaemia in the prematurity 
At birth, the normal infants have higher haemoglobin and haematocrit levels than older 
children and adults. Their concentrations of haemoglobin and haematocrit decline in the first 
three months of life. The magnitude ofthe decline in preterm infants is greater than that ofterm 
infants and, thus, anaemia is seen earlier in them (Fig.l) (Stockman JA, 1986). This phenomenon 
has been termed "physiologic" anaemia of infancy based on the fact that most of the infants seem 
to tolerate low level ofhaemoglobin concentration without showing any symptoms. 
In healthy term infants and asymptomatic growing premature infants, physiologic 
anaemia requires no therapy. However, if signs and symptoms suggesting that hypoxia has 
developed, packed red blood cell transfusion may be required. Unlike the older children and 
adults, it is difficult to develop a clear cut criteria for transfusion for premature infants since they 
undergo serial hematological changes after birth. In recent years, recombinant human 
erythropoietin (rHuEpo) has been introduced for treating low birth weight infants so as to 
increase their rate of red blood cell production and thus, avoiding transfusion. 
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1.11 Erythropoiesis and Erythropoietin 
Haemopoiesis is different in intrauterine life from after birth. There are several sites for 
fetal haemopoiesis which can be divided into three periods: mesoblastic, hepatic, and myeloid 
(Fig.2). Erythropoiesis begins by the 3'^  week of gestation. Blood islands in the yolk sac first 
produce erythrocytes and leukocytes. Up to the 5^ and 6^ week in an embryo, erythropoietic 
activity is present in the liver which becomes the primary site of red cells formation from the 9^ 
to 24^ weeks of gestation (Bloom W and Bartelmez GW, 1940; Migliaccio G et al., 1986). 
Erythropoiesis is first seen in the marrow of the 10^ to 11^ week embryo (Bloom W and 
Bartelmez GW, 1940; Gilmour JR, 1942), and the marrow become the major site of 
hemopoiesis after the 24^ week of gestation. At birth the whole marrow cavity is utilised for 
haemopoieses and it is the major blood producing organ. Thymus, kidney and spleen also 
participate in haemopoiesis during the second trimester. In premature infants, it may have 
significant extramedullary hematopoiesis with limited bone marrow haematopoiesis. 
Red cell production is normally regulated by erythropoietin (Epo) which is a glycoprotein 
growth factor. It is initially produced by the liver during fetal life. A gradual shift of 
production to the kidney during the last trimester follows (Flake AW et al., 1987). After 
\ 
erythropoietin is released into the circulation, it binds to and activates the receptor on the red 
blood precursor in the bone marrow. It acts on the erythropoietic stem cell stimulating its 
proliferation and reducing ineffective erythropoiesis. Epo level increases with gestational age 
but it falls after the onset of respiration at birth, when oxygen in the lungs saturates the 
haemoglobin in the arterial blood. Erythropoiesis almost ceases after birth. The production of 
erythropoietin is in response to the oxygen supply: it decreases in response to transfusion and 
increases by anaemia or hypoxia (Schooley JC and Mahlmann LJ, 1975). 
2 
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In premature infants, the amount of Epo produced in response to anaemia is relatively 
low when compared to the older individuals (Dallman PR, 1981; Stockman JA III, 1986; 
Strauss RG, 1995). It is believed that the liver still remains the primary site of Epo production 
rather than the kidneys in premature infants during the first weeks of life (Brown MS et al., 
1984). This dependency on hepatic production of Epo is important since the stimulation of the 
hepatic production ofEpo appears to be less sensitive to anaemia than to renal production. The 
diminished Epo output in premature infants may limit their compensatory response to anaemia. 
1.12 Postnatal changes in oxygen transport and delivery 
1. Structure ofhaemoglobin molecule 
Haemoglobin is a complex protein inside the red blood cell, which can combine 
reversibly with oxygen. This allows red blood cells to pick up oxygen from the lung and deliver 
it to the tissues. Haemoglobin is a tetramer made up of two pairs of polypeptide chains, consist of 
either a, p, or y chains. Each chain has an iron-cointaining heme group attached to it. There are 
different haemoglobins detected within the red blood cells at different period of life (Fig.3): the 
embryonic haemoglobins, Gower-1, Gower-2, and Portland; the fetal haemoglobin, Hb F; and 
adult haemoglobins, Hb A and ki. The first three kinds of embryonic haemoglobins are present 
in the blood ofearly human embryos. 
Hb F is composed of two alpha and two glamma chains represented as a2y2 and is 
present after the 8^ gestational week. It remains the major haemoglobin of fetal life (Pataryas 
HA and Stomatoyannopoulos G, 1972) (Fig.2). Haemoglobin A is composed of two alpha and 
two beta chains (a2p2). It can be detected at about 9^ week of gestation (Thomas ED et al., 1960; 
3 
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Kazazian HH and Woodhead AP, 1973). After 34 to 36 weeks of gestation, the percentage ofHb 
A rises, while that ofHb F decreases. In the 16 to 20 week old infant, Hb F constitutes about 3% 
ofall haemoglobin synthesized (Bard H, 1975). After 6 months of age, more than 90% of total 
haemoglobin is Hb A. Hb F is no longer present. 
2. Postnatal changes in haemoglobin concentration of infants 
At birth the cord blood haemoglobin concentration averages 16.8g/dl in normal infants 
with a range of 14-20g/dl (Letsky EA, 1992). This high haemoglobin level of the fetus is due to 
fetal erythropoietin production in the liver in response to low PO2 in utero. After birth, a 
progressive fall in haemoglobin concentration in infants caused by factors such as the reduction in 
red blood cell production, the rapid destruction red blood cells, and the expansion in blood 
volume with growth. The haemoglobin level may fall to 9-11 g/dL at 2-3 months ofage in full-
term infants. In premature babies, the fall in haemoglobin concentration occurs more rapidly and 
more profound. Minimal levels of 7-9 g/dL commonly occur by 3-6 weeks of age (Schwartz E, 
1996). The rapidity and the magnitude of the fall is proportional to the immaturity of the infant. 
Total haemoglobin concentration and haematocrit rise during childhood, reaching adult values 
after puberty. 
i. Postnatal changes in oxygen affinity ofhaemoglobin 
The oxygen affinity undergoes major changes after birth. This alteration in the affinity of 
the haemoglobin for oxygen plays an important role in regulating oxygen release in the preterm 
neonate. At birth, up to 60-80% ofhaemoglobin is Hb F. Anselmino and Hoffman first observed 
that the oxygen affinity ofhuman fetal blood was greater than that of maternal blood (Anselmino 
KT and Hoffman F, 1930). This was understood when it was demonstrated that Hb F had a 
4 
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greater affinity for oxygen than Hb A did due to its less effective binding to 2,3-
diphosphoglycerate (2,3-DPG), an intermediate metabolite of the glycolytic pathway. 
Red blood cell has a high concentration of 2,3-DPG. Since there is a binding site for 2,3-
DPG in the central cavity of deoxyhaemoglobin (Fig.4), the deoxygenated form of haemoglobin 
can be stabilized by binding to 2,3-DPG. By competing for oxygen-binding sites, 2,3-DPG can 
decrease the affinity of haemoglobin for oxygen as a result (Adamson JW and Finch CA, 1975; 
Benesch R and Benesch RE, 1967). The level of red cell 2,3-DPG gradually increases with 
gestation, and is similar to that of the adult at term (Lister G et al., 1979). However, the levels of 
2,3-DPG was lower in premature infants than term infants. 
It is more easily understood when comparing the oxygen affinity for Hb A to that for Hb 
F using the oxyhaemoglobin dissociation curve. The oxygen dissociation curve (Fig.5) is derived 
by plotting the percentage saturation of haemoglobin and the partial pressure (PO2) under 
standard in vitro conditions of pH and temperature. Oxygen affinity is usually demonstrated by 
P50 which is defined as the partial pressure of oxygen at which haemoglobin is half saturated with 
oxygen. In adults the P50 averages 27 torr (mmHg) whereas in fetus and infants, there is an 
average P50 of 18-22 torr (Dallman PR, 1981). By comparing the dissociation curve of adult to 
that of infant, the curve is shift to the left in the fetus and newborn. The left-shift of the curve 
which means a higher oxygen affinity of Hb F benefits the fetus in utero since it facilitates 
placental oxygen exchange from matemal blood to fetal erythrocytes. However this is 
disadvantageous to the newborn as a consequence of the decrease in the amount of oxygen 
released to tissue. Until three months of age, the curve gradually shifts to the right, 
approximating that of the adult by 4 to 6 months of age in term infants. However, the switch 
from fetal to adult haemoglobin occurs at a later stage of postnatal life in preterm infants (Bard H, 
1975). 
5 
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The change from fetal to adult haemoglobin begins at approximately 32 weeks' gestation. 
Thereafter, the percentage of fetal haemoglobin decreases and that of Hb A increases in the 
following 6 months. After the replacement of Hb F by Hb A, the capacity of haemoglobin to bind ； 
？ 
DPG increases (Delivoria-Papadopoulos M, Roncevic N and Oski FA, 1971; Versmold H, Seifert | 
G and Riegel KP, 1973). This is favorable for the release of oxygen to tissues. 
Since preterm infants have low levels of erythropoietin, erythropoiesis decreases shortly 
after birth. However, the shortened life-span of fetal red blood cell, and the expansion of blood 
volume that accompanies rapid weight gain may increase the need of erythropoiesis. Thus, 
premature infants experience a significantly more decreased haemoglobin concentration. At the 
same time, the fetal haemoglobin has high oxygen affinity. These resulted in decreased amount 
ofoxygen released to tissue. They are at a great risk for poor oxygen delivery and tissue hypoxia. 
1.2 The concept of oxygen supply and demand 
Oxygen "supply" can be expressed by systemic oxygen transport (SOT) which can be 
calculated as the product of cardiac output (CO) and arterial oxygen content (CaO2): 
SOT=CO X CaO2 
where CaO2 can be determined by (SaO2) x [Hb] x 1.34 ml O2/gHb (the in vivo oxygen-carrying 
capacity of haemoglobin) (Alverson DC et al., 1988). From the above formula, it is known that 
systemic oxygen transport can be affected by either the cardiac output, the haemoglobin oxygen 
saturation ofarterial blood, or the concentration ofHb. 
Oxygen "demand" of the whole body can be reflected by systemic oxygen consumption 
(VO2). Oxygen consumption is normally independent of changes in oxygen delivery (Guyton 
6 
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AC, Jones CE and Coleman TC, 1973; Shepherd AP et al., 1973). If SOT is diminished by a 
decrease in any of its substrates (CO, SaO2, Hb), oxygen extraction will increase to maintain the 
oxygen consumption. However, when systemic oxygen transport is severely curtailed, the ! 
oxygen consumption may become dependent on and limited by oxygen supply (Adams RP, 
Dieleman LA and Cain SM, 1982; Cain SM, 1977). Oxygen consumption will fall in parallel 
with further decreases in systemic oxygen transport. If the condition is uncorrected, the impaired 
systemic oxygen transport may lead to cell damage (Alverson DC, 1995). 
The relationship of oxygen supply and demand has been described as the oxygen 
extraction ratio by Lister et al., calculated as the ratio of oxygen consumption to systemic oxygen 
transport, VO2/SOT. It describes the percentage of oxygen consumed from the total amount 
transported and serves as an index of overall oxygen utilization (Lister G et al., 1984). Normally 
the oxygen extraction ratio ranges from 0.15 to 0.33 (Alverson DC, Isken VH and Cohen RS, 
1988; Lister G et al., 1984, Lister G et al., 1979). This ratio varies from organ to organ and with 
levels of activity. Numerous studies indicate that when the oxygen extraction ratio exceeds 0.4， 
organ and cellular dysfunction begins to occur (Levy GJ et al., 1992; Lister G et al., 1984; van 
Woerkens ECSM, Trouwborst A and van Lanschot JJB, 1992). 
bi infants, some parameters which can affect the SOT undergo changes after birth. The 
most important of them are the reduction in the concentration ofhaemoglobin and the decrease in 
the affinity ofhaemoglobin and oxygen. Since these variables interact dynamically and in many 
cases dependently, it is difficult to determine an absolute threshold of haemoglobin concentration 
or level ofhaematocrit as an index to define significant anaemia. 
7 
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1.3 Compensatory response and adverse effects ofanaemia 
When anaemia occurs, it may lead to cellular hypoxia. Compensatory responses are 
aroused in order to improve oxygen delivery to the tissues. For example, oxygen supply can be i 
1 
increased which can be reflected by the increase in cardiac output and respiratory effort. The 
increase in cardiac output is often reflected by tachycardia (Alverson DC, 1995). tivestigators 
demonstrated a fall in heart rate (Lachance C et al., 1994; Nelle M et al., 1994; Joshi A et al., 
1987) and even in cardiac output (Lachance C et al., 1994; Alverson DC, 1988) to normal levels 
after red cell transfusion. 
The increased respiratory effort to improve PaO2-SaO2 is reflected by tachypnea as a 
result of stimulation of the respiratory drive during hypoxic stress (Alverson DC, 1995). But 
several studies failed to show a correlation between respiratory rate and the haematocrit level nor 
any changes in respiratory rate after transfusion (Alverson DC, Isken VH and Cohen RS, 1988; 
Joshi A et al., 1987; Keyes WG et al., 1989). 
Oxygen consumption can be increased as cardiac and respiratory work increase in 
response to hypoxia. It has been shown that oxygen consumption and oxygen extraction ratios 
are higher when anaemia occurs and fall after transfusion (Alverson DC, Isken VH and Cohen 
RS, 1988) particularly in subjects with oxygen extraction ratios greater than 0.4 (Alverson DC, 
Isken VH and Cohen RS，1988; Lachance C et al., 1994; Stockman JA III, 1986). In some cases, 
oxygen can be reapportioned to most vital tissues if the oxygen supply is limited, or the metabolic 
demands can be reduced to survive this critical oxygen supply-demand imbalance (Lister G, 
1993). A decrease in oxygen consumption may be reflected by diminished activity or lethargy in 
infants. Fahey and Lister compared metabolic response of premature lambs and showed that 
during a period of critically low cardiac output, the more immature subject not only had 
8 
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decreased oxygen consumption, but also had decreased metabolic demands (Fahey JT and Lister 
G, 1989). 
Lastly, the increase in erythropoiesis is reflected by the increase in erythropoietin (Epo) 
level. Erythropoietic response to hypoxia is decreased in the premature infant compared to the 
older child or adult (Dallman PR, 1981; Stockman JA III, 1986; Strauss RG，1995). Stockman 
described that the erythropoietin levels were uniformly elevated when the measured mixed 
venous oxygen tension reached 30 torr or less, and with the haemoglobin concentrations of less 
than 8 g/dL in their group of premature infants (Stockman JA III’ 1984). However, erythropoiesis 
response in premature infants is limited since the liver site for erythropoietin production which is 
hyposensitive to hypoxia remains to be predominant for a longer period after birth than that in 
term infants (Dallman PR, 1993). 
1,4 Treatments of anaemia 
1.41 Red blood cell Transfusion 
Since physiologic anaemia is self-limited, healthy term infants and asymptomatic 
growing premature infants require no therapy. However, if signs and symptoms suggesting 
hypoxia is present, red cell transfusion may be required. The use ofblood transfusion in neonatal 
intensive care unit has become increasingly common over the past few decades. It has estimated 
that over 80% of infants requiring intensive care received at least one blood transfusion as part of 
their treatment, and 37% of them received more than two. Exposure to multiple donors is also 
frequent (Brown MS, Berman ER and Luckey D，1990). In United States, premature neonates 
with birth weight less than 1.5 kg usually require multiple red blood cell transfusion, and many of 
9 
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them receive cumulative transfusion volumes in excess of their own total blood volumes (Kim 
HC, 1983; Sacher RA, Luban NL and Strauss RG, 1989). 
1, Development of transfusion medicine 
The first animal transfusion was demonstrated by Lower and co-workers in 1665s (Lower 
R, 1666a; Lower R, 1666b; HoffEC and HoffPM，1936) by direct transfusion from the carotid 
artery of one dog to the jugular vein of another. These studies led to the transfusion of animal 
blood to human. The first human transfusion was performed by Denis in 1667s who administered 
the blood of a lamb to a 15 years old boy (Denis J, 1667). Although the first two subjects 
transfused by Denis succeeded without any adverse effects, both the third and fourth recipients 
died. The death of the third case can be attributed to other causes. The fourth case died of 
transfusion reaction which was not known at that time (Denis J, 1668). Since then, transfusion 
research went into decline, and within 10 years it was prohibited in both France and England 
(Rossi EC et al., 1996). Until 1818s，Blundell stated that only human blood should be used for 
human transfusion (Rossi EC et al., 1996). He then performed the first well-documented 
transfusion with human blood in the same year. Thereafter human transfusions were 
continuously practiced. However, not all of the transfusions succeeded. Transfusion at the end of 
19^ century was neither safe nor efficient. 
Transfusion practice was rekindled by the scientific and technical advances at the 20^ 
century (Rossi EC et al., 1996). A monumental discovery of the sera of some individuals 
agglutinated the red cells of others was observed by Landsteiner (Landsteiner K, 1901), which led 
to the identification ofthe blood groups A, B, and 0 and the group AB by Decastello and Sturli 
(Decastello A and Sturli A, 1902). Ottenberg began pretransfusion compatibility testing in 1907 
(Ottenberg R, 1908) and he was the first to recognize the relative unimportance of donor 
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antibodies and the "universal" utility of type 0 blood donors (Ottenberg R, 1911). The Rh 
system was discovered in 1939s by Levine and Stetson (Levine P and Stetson RE, 1939). 
After the introduction of anticoagulants and the development of new methods and 
techniques, blood transfusion was given in increasing numbers and has become safe and easy to 
perform nowadays (Rossi EC et al, 1996). 
2. Transfusion practice in neonates 
Blood transfusions are usually applied under one of two circumstances. The first 
situation is replacement of acute blood loss resulting from laboratory studies. This kind of 
frequent blood sampling is necessary especially when monitoring an sick infant with severe 
respiratory disease requiring oxygen or ventilator support. Shannon described that moderately ill 
infants weighing less than 1250 gram can lose almost 50 ml of blood as the result of sampling 
during the first three weeks of life (Shannon KM et al., 1995). It is customary to maintain the 
haematocrit above 40 per cent regardless of the quantity of blood drawn for testing (Strauss RG, 
1994). 
The second circumstance in which blood transfiision is administered is frequently 
referred to as anaemia of prematurity. Although premature infants often receive frequent 
transfusion during the first few weeks of life, there are no generally accepted transfusion 
guidelines available and the transfusion practices vary considerably in different centres. The 
prescription oftransfusion is usually based on the clinical signs and symptoms including feeding 
difficulties, poor weight gain, dyspnea, tachycardia, tachypnea, diminished activity and pallor 
(Gairdner D, Marks J and Roscoe JD, 1952). 
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Many ofthe blood transfusions in premature infants are given in the first postnatal week 
(Dallman PR, 1993). Gestational age and the initial haemoglobin concentrations have been 
suggested as the predictor of later transfiision need in the premature infants. Brown found that 
infants bom at a gestational age of less than 30 weeks received more transfusions in contrast to 
those with older gestational age (Brown MS, Berman ER and Luckey D, 1990). Holland also 
found that infants with higher initial haemoglobin values did not develop clinical symptoms 
associated with anaemia later when comparing to those whose haemoglobin concentration was 
less than 150 gfL (Holland BM and Wardrop CAJ, 1991). 
A number of studies were carried out to demonstrate the effects of transfusion on the 
above mentioned signs and symptoms. Wardrop suggested that it was beneficial to premature 
infants to have "booster" transfusions to maintain haematocrit levels. (Wardrop CAJ et al., 1978). 
But Blank found no clinical advantages in the routine use of small-volume red blood cell 
transfusions in stable premature infants (Blank JP et al., 1984). Stockman and co-workers 
believed that poor weight gain was a clinical indication for transfiision. They demonstrated in 
1984 that there was increased weight gain associated with decreased metabolic rates in anaemic 
premature infants after red blood cell transfiision (Stockman JA III and Clark DA, 1984). 
Kattroinkel described that apnea might be due to diminish oxygen delivery to the central nervous 
system. He suggested that there was a correlation between the development of apnea in 
premature infants and low levels of haemoglobin (Kattroinkel J, 1977). Joshi also showed that 
red blood cell transfusion could diminish irregular breathing patterns and episodes ofbradycardia 
in their group of infants (Joshi A et al., 1987). But Keyes found that there was no significant 
relationship between haematocrit and the symptoms, nor was there a benefit of red blood cell 
transfusion on breathing patterns in premature infants (Keyes WG et a/.,1989). 
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3. Risks of red blood cell transJusion 
Although red blood cell transfusion is potentially life saving and usually beneficial, there 
are adverse secondary effects in some instances. Graft-versus-host disease (GVHD) may occur 
following transfusion in newborn (Sanders MR and Graeber JE, 1990). Also, hemolytic 
transfusion reaction, fluid overload, electrolyte, acid-base imbalances and immunosuppression 
(Pahwa S et al., 1985) are the risks associated with transfiision. Of great concern is the 
transmission of infectious agents through blood transfusion which included the human 
immunodeficiency virus (HIV), hepatitis viruses (type A, type B, non-A, non-B) and 
cytomegalovirus (CMV). 
i. 42 Recombinant human erythropoietin (rHuEpo) 
The aetiology of anaemia of prematurity is still not known. Erythropoietin deficiency 
and other factors may all contribute to the cause of anaemia including the shortened life span of 
neonatal erythrocytes, expansion in blood volume resulted in the rapid growth and large 
phlebotomy losses for laboratory tests (Alverson DC, Isken VH, Cohen RS, 1988). 
In 1987, recombinant human erythropoietin was tested in the treatment of patients with 
chronic renal disease (Eschbach JW et al., 1987). Anaemia of these patients were corrected and 
the transfusion requirement eliminated. After a short while, recommendation was made by the 
National Kidney Foundation that recombinant human erythropoietin be used in routine treatment 
for patients with the anaemia of chronic renal disease (Ad Hoc Comm, 1989). 
In recent years, the use of recombinant human erythropoietin has been shown to be 
effective in reducing the number of transfusions required in the management ofpremature infants 
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(Shannon KM et al., 1995). This is especially so during their second and third postnatal months 
when most of them reach their lowest haemoglobin concentrations. It has been suggested that 
weekly doses of rHuEpo of 300 IU/kg to 1400 IUy1cg enhance erythropoiesis in preterm infants 
(Shannon KM et al., 1995). However, the prospects of using regular injection of rHuEpo to 
prevent transfusions during the first two weeks oflife are poor. Even if rHuEpo are started on the 
day ofdelivery, the beginings of the effect cannot be seen until the second week due to a delay in 
haemoglobin response after therapy (Dallman PR, 1993). 
Adverse effects included early mortality or neutropenia can also be induced by rHuEpo 
OVilliamson P, 1996). The increased risk of cot death has also been suggested in one trial 
(Emmerson A, 1993). Since erythropoiesis requires sufficient iron to be incorporated into red 
cells (Brugnara C, 1993), decreased serum iron and ferritin concentrations can be seen as a result 
of mobilisation of iron by stimulated erythropoiesis (Maier RF et al., 1996). There are many 
questions that need to be solved with respect to the dosage, timing, duration and tapering of 
rHuEpo administration to allow for stimulating endogenous erythropoietin production (Dallman 
PR, 1993). In addition, the requirments for iron, folate, and other supplements of the infants 
receiving rHuEpo have not been well studied. 
In comparison, red cell transfusion provides a rapid increase in red cell mass and 
haemoglobin while erythropoiesis increases red cell mass and haemoglobin concentration more 
gradually. Both methods have theirs own advantages and risks. 
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1.5 Methods of cardiac output measurements 
Cardiac output is the amount ofblood ejected by the heart in liters per minute which was 
delivered to the systemic circulation. It is probably the most important hemodynamic 
measurement to assess the patient's perfusion status. It is the product of stroke volume and heart 
rate. Several methods have been introduced to measure cardiac output in humans. At present, 
invasive methods of measuring cardiac output include the Fick oxygen method, the indicator 
dilution method, thermodilution techniques and the angiographic approach. Non-invasive 
methods include the analysis of arterial pulse waves, the doppler ultrasonography, the thoracic 
electrical bioimpedance and the CO2-rebreathing method. Some of the methods will be 
elaborated in the following paragraphs. 
1,51 Determination of cardiac output by invasive method 
1, The FickMethod 
In 1870，Adolf Fick described a method to determine cardiac output: "The total uptake or 
release o fa substance by an organ is the product ofthe blood flow to the organ and the difference 
ofarteriovenous concentration of the substance" (Fick A, 1870). It was first applied in animals at 
the end of the nineteenth century. It depends on the measurement of the oxygen concentration 
and the difference in oxygen content between venous and arterial blood. It requires sampling of 
mixed venous blood from the pulmonary artery and arterial blood from any peripheral artery. 
Concomitantly, oxygen consumption (VO2) is determined from samples of expired gas collected 
in a Douglas bags (Douglas CG, 1911) attached to a metabolic rate meter. This technique was 
applied to humans after the development of right heart catheterization in the 1940s. Cardiac 
output can then be calculated as follows (Corin WJ & Santamore WP, 1993): 
Cardiac Output (L/min) = Oxygen Consumption / Arteriovenous oxygen difference 
15 
Literature review 
The Fick method is accurate and reliable. It remains the gold standard of accuracy since 
1920s. In the absence of an intracardiac shunt, pulmonary and systemic blood flow are equal. 
The error in determining the arteriovenous oxygen difference and the total error using this method 
is about 10% (Visscher MB and Johnson JA, 1953). It assumes that the patient is in a metabolic 
steady state that VO2 and cardiac output remain stable during the period of measurement. The 
procedure requires establishment of a steady state for several minutes. In fact, the measurement 
can be influenced by the patient's ventilatory rate, temperature and barometric fluctuations 
O^ishikawa T and Dohi S，1993). 
2. The indicator dilution method 
It was developed by Stewart in 1897 (Stewart GN, 1897). The first measurement of 
cardiac output in man using this technique was demonstrated by Hamilton (Hamilton WF, Moore 
JW and Kinsman JM, 1932). bidictor dilution method became widely applied in the 1950s. 
Indicator such as indocyanine green was injected into the venous circulation. The dye passed 
through left side ofthe heart and got mixed with blood. The blood-dye solution was continuously 
withdraw from a systemic artery such as brachial, radial and femoral arteries through a 
densitometer and the resultant time-concentration curve could be determined. Cardiac output was 
accessed by: 
Q = I / i C (t) dt (Dodge HT and Kennedy JW, 1985) 
where Q, the cardiac output; I，the known quantity of indicator; and C, the mean concentration of 
the indicator during the time (t) from the appearance to disappearance of the indicator as 
determined from the time-concentration curve. 
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The method generates an accurate cardiac output without the need to determine oxygen 
consumption and the need to measure the hemoglobin or oxygen saturation. Gessner performed a 
cardiac output measurement with this technique in 14 term infants and found a mean cardiac 
output of 254i53 mL/min/kg in 1965s (Gessner EH et al., 1965) while Emmanouilides also had 
the similar result in his group of 23 term infants with the mean cardiac output value of 246士95 
mL/min/kg (Emmanouilides GC et al., 1970). However, the accuracy of indictor dilution method 
depends upon the ability to separate the dye concentration due to the first pass and recirculation. 
The indocyanine green itself affects the oxymetric blood oxygen saturation. Its accumulate 
within the circulation may lead to decreased accuracy of late measurements (Corin WJ and 
Santamore WP, 1993). There is also an increased risk of allergic or toxic reactions to the 
indicator dye. 
3. Thermodilution technique 
Thermodilution technique is similar to the indicator dilution technique but it uses warm 
or cool saline instead of the indocyanine green dye as an indicator. It was first introduced by 
Fegler in anaesthetized dogs in 1954 (Fegler G，1954; Fegler G，1957). After the development of 
the balloon-tipped, flow-directed, multiple lumen pulmonary artery (PA) catheter by Swan, Ganz 
and Forrester et al. (Ganz W et al, 1971; Ganz W and Swan HJC, 1972; Forrester JS et al, 1972) 
and Ellis et al. (Ellis RJ et al, 1972), the technique has become more practicable and has been 
widely applied in the management of critically ill patients. 
A known amount ofcold indicator is injected into the right atrium through the right atrial 
port of a catheter which it was detected by a thermistor located at its distal end, situated in a 
pulmonary artery. The pulmonary artery blood temperature is sampled by the thermistor which is 
coupled to a computer. Measurement of the concentration of the cold indicator (C) in the 
17 
Literature review 
pulmonary artery over time (t) was talken after the introduction of cold indicator (I). All ofthe 
indicator passes downstream can be assessed by: 
I = Q J C(t)dt (Corin WJ and Santamore WP, 1993) 
where Q is the cardiac output. After rearrangement of the formula, cardiac output can be 
calculate as: 
Q = I/ fCWdt 
It is a highly accurate and more reproducible method of measuring cardiac output than 
dye dilution or Fick method (Nishikawa T and Dohi S，1993)，with an approximate error of 5 to 
10% (Grossman W, 1986). It does not required withdrawal ofblood, and can be repeated at short 
intervals. However, since this method requires insertion of a Swan-Ganz catheter, it has the 
potential risk of inducing complications such as arrhythmias and pulmonary artery rupture (Patel 
C et al., 1986; Sise MJ et al., 1981; Horst HM et al., 1984). Factors such as the temperature and 
volume of injectate, the timing, speed and the mode of injection, rewarming of injectate, catheter 
dysfunction and position, the paediatric patients or other conditions are also responsible for the 
errors of cardiac output estimation by this thermodilution method (Nishikawa T and Dohi S, 
1993). 
In infants and children, cardiac output measured by thermodilution method has good 
correlation with values obtained by using the Fick method or dye dilution technique (Colgan FJ 
and Stewart S, 1977; Freed MD and Keane JF, 1978; Alfieri 0 and Subramanian S, 1975). 
However, since only a small volumes of cold injectate is injected into the body, if the blood at 
body temperature is withdrawn into the injection lumen of the catheter before the injection, the 
amount of heat gained by the cold injectate during passage through the catheter may lead to 
overestimation ofcardiac output (Maruschak GF et al., 1982). 
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4. Angiocardiography technique 
Injection of iodinated contrast material into the left ventricle permits direct fluoroscopic 
and cineangiographic visualization of the ventricular silhouette. The left ventricular volume can 
be calculated from the two-dimensional image of the left ventricle and in tum (Corin WJ and 
Santamore WP, 1993), cardiac output (CO) is calculated as the product of stroke volume (SV) 
and heart rate (HR): 
CO = (End diastolic volume - End systolic volume) x Heart rate 
It permits beat-to-beat data to detect rapid changes in cardiac output. But the cardiac output 
determined by this method is usually greater than that obtained by Fick or thermodilution method, 
and the injection of contrast medium may cause ventricular arrhythmias as well as an increase in 
intravascular volume. 
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1.52 Determination of cardiac output by non-invasive methods 
1. Echocardiographic measurement of left ventricular volumes 
Although thermodilution and the Fick method have been accepted as standard methods 
for measurement of cardiac output in critically ill patients, they require insertion of arterial and 
venous catheters and withdrawal of blood samples which may be difficult in neonates. 
Echocardiographic assessment of cardiac output is noninvasive and accurate. In addition, the 
technique can be leamed easily and used safely. It is well tolerated by the patient and probably is 
the best method for serial measurements. 
a) M-mode echocardiography 
M-mode echocardiography was initially described by Edler et al in 1954 (Edler I and 
Hertz CH, 1954). It remains a useful tool for ultrasonic study of the heart for nearly two decades 
(Picard MH, 1994). Left ventricular volumes can be determined by cubing the left ventricular 
dimensions (D): 
V = (D)3 
Stroke volume (SV) can be calculated as the difference between the left ventricular end diastolic 
volume (LVEDV) and the end systolic volume (LVESV) (Silverman NH, 1993): 
SV = LVEDV - LVESV 
Cardiac output (CO) can be determined by the product ofheart rate and stroke volume. 
M-mode echocardiography is the earliest and one of the widely used methods for left 
ventricular volume calculation. However, using left ventricle dimension to calculate left 
ventricular volume is based on the assumptions that the left ventricle resembles a prolate ellipse 
20 
Literature review 
with the long axis (L) of the left ventricle twice the length of the short axis (D) (Popp RL and 
Harrison DC, 1970; Pombo JF, Troy BL and Russell R0, Jr.,1971), that is, L=2D. The left 
ventricular wall motion sampled by the ultrasound beam is respresentative of the entire left 
ventricular chamber (Felner JM and Schlant RC, 1976). 
Since the shape of the left ventricle varies with heart size, the assumption L=2D is not 
valid for all ventricles. Teichholz et al. analyzed left ventriculograms in the right anterior oblique 
projection of 100 patients and demonstrated the range of L/D ratios in their groups of patients 
from 1.2:1 to 3.2:l(Teichholz LE etal., 1976). With the use of the standard angiographic volume 
formula V = 7i/6D^L and the determined relation between L and D, that is，l/(L/D) = 0.075D + 
0.18, he modified the diameter cube formula for calculating volume (Teichholz LE et al., 1976): 
V = { 7 / ( 2 . 4 + D)} (D)3 
C E > 
^ K ^ ) - H 
Fig.6 (FollandED etal., 1979) 
This modified volume formula allows direct determination of left vetricular volume using the 
intemal dimension obtained by ultrasound. This has been proved to be more accurate than other 
M-mode equations for left ventricular volume calculation (Silverman NH et al., 1980). However, 
the M-mode method is not reliable in the presence of asynergy (Teichholz LE et al., 1976) and 
can only be applied when the left ventricular contraction is uniform and symmetrical. 
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b) Two-dimensional echocardiography 
After the development of two-dimensional echocardiography, there is improved accuracy 
in the measurements of cardiac chamber volumes. Methods for measurement are based on the 
geometric model that allows estimation of the entire volume from one or a few cross-sectional 
images. For example, the ellipse single model, the ellipsoid biplane model, the hemisphere-
cylinder (or bullet) model, and the Simpson's method (Folland ED et al., 1979; Silverman NH et 
al., 1980; Mercier JC et al., 1982) have been suggested for the calculation of left ventricular 
volume. The following are brief introductions of these methods. 
• Ellipsoid single-plane model 
The left ventricle is assumed to be ellipsoid (Mercier JC et al., 1982). Area (A) and 
length (L) from the apical echocardiographic image are substituted into the equation (Kennedy 
JW, Trenholme SE and Kasses IS，1970): 
Volume = 0.85A2 /L 
€ 3 . 
I L 1 
Fig.7 (Folland ED et a/.,1979) 
22 
Literature review 
• Ellipsoid biplane model 
By measuring the longest length (L) form apical four-chamber view and the orthogonal 
minor-axis diameters (Di) (D2) from the short-axis view at the mitral valve or papillary muscle 
level, left ventricular volume is determined as (Mercier JC et al., 1982; Dodge NT et al., 1960): 
Volume = 71/6 (L) (Di) (D2) 
藝 
Fig.8 (Folland ED et al., 1979) 
• Hemisphere-cylinder model 
The left ventricle is divided equally. The volume of a cylinder is add to the volume of a 
half ellipse. The cross-sectional area (A) at the mitral valve level and long axis (L) from the 
apical four-chamber view are used to the formula (Mercier JC et al., 1982): 
Volume = L/2 (A) + 2/3 (A) L/2 = 5/6(AL) 
A ~ " p T ^ 
A 丨A 
U _ 0 ^ 
^ i - ^ i ^ 
Fig.9 (Folland ED etal., 1979) 
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• Simpson 's method 
Simpson's method divides the left ventricle into slices of known thickness, and the 
volume of the left ventricle is calculated from the sum of the volumes ofthis series of slices. The 
volume of slices are acquired with the use of multiple short-axis views. This method applies two 
geometric models. 
In the first model (Fig.lO), the left ventricular volume can be determined by assuming the 
volume of the ventricle to be the sum of a cylinder (from the base of the heart to the mitral valve), 
a truncated cone (from mitral valve to mid-papillary muscle), and below this another cone to the 
cardiac apex (Mercier JC et al., 1982): 
V o l u m e = L / 4 { A ! + (A1+A2)/2 + (A2+A3)/2 + l / 3 A s } 
r ^ ^ f ^ i ^ T ^ 
^1； Ai； A2; A 3 ; � 
V •• vJ \L\f 
U i _ j ^ i ^ k ^ k ^ . 
I 4 4 丨 4 4 • I 
Fig.lO (Mercier JC et al., 1982) 
In the second model (Fig.ll), the left ventricle volume is estimated as the sum of small 
cylinders and a truncated ellipse (Mercier JC et al., 1982): 
V o l u m e = L / 3 ( A 1 + A 2 ) + (A3/2) L / 3 +n/6 {L/3f 
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) ^ 3 
Fig.ll (Mercier JC etal., 1982) 
where L is the longest length measured from the apical four-chamber view. A! is the area of the 
short axis at the mitral valve level, A2 the area of the short axis at the tips of the papilly muscles, 
A3 the area of the short axis at the base of the papillary muscles. 
The concept of Simpson's method was further supported by studies in which 
echocardiography was used to measure left ventricular mass and volumes in dogs (Wyatt HL et 
al., 1979). It appeared to be a very reliable method since it did not require the assumption about 
the geometry of the ventricles and was relatively not affected by segmental wall motion 
abnormalities (Tajik AJ et al., 1978; Hagan AD et al., 1983; Wahr DW, Wang YS and Schiller 
NB, 1983). 
Previous investigators have reported the accuracy of using two-dimensional 
echocardiography in the assessment of left ventricular volume in both adult and paediatric 
patients and have shown that two-dimensional echocardiograpy is superior to M-mode 
echocardiography for estimating left ventricular volume (Gehrke J et al., 1975; Roelandt J, 1974; 
Schiller NB et al, 1979; Folland ED et al., 1979). 
The left ventricular volume measured by two dimensional echocardiography is usually 
smaller when compared with that determined by angiography. It can be explained by reasons of 
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the foreshortening of the apex, the exclusion of the papillary muscles and the inherent volume 
overestimation of contrast techniques resulting from contrast filling of trabecular interspaces 
(Schiller NB et al., 1989). However, the two dimensional echocardiographic measurements had 
proved reliable when tested by interobserver and intraobserver methods (Wahr DW, Wang YS 
andSchillerNB, 1983). 
c) Doppler echocardiographic assessment 
Unlike the M-mode or two dimensional echocardiography, Doppler echocardiography 
allow estimation of the left ventricular blood flow velocity, acceleration rate, and volume output 
without the need for left ventricular geometric assumptions. 
Doppler examination is based on the Doppler principle first described by an Austrian 
physicist, Chirstian Johann Doppler, in 1842. Doppler stated that sound reflected or generated 
from a moving object would be shifted in frequency relative to the speed of that moving object 
(Alverson DC, 1985). From Fig.l2A, ultrasound is emitted from a given frequency through a 
r 
piezoelectric crystal. The ultrasound beam can be directed at any object and the reflected echoes * 
is recorded by the receiving mode of the transducer (R). The Doppler shift frequency is detected 
by analyzing the transmitted and received signals in the receiving crystal and amplifier. If the 
moving object such as red blood cells are moving towards the transducer, the received frequency 
is increased (Fig.l2B). On the contrary, ifthe object is moving away from the transducer, the 
frequency of the received ultrasonic beam is less than the transmitted frequency (Fig. 12C). Since 
the Doppler examination allows recording of the movement of red cells, this technique provides a 
direct and accurate assessment of the blood flow in the cardiovascular system. The first device 
that combined real-time two-dimensional imaging with simultaneous pulsed Doppler flow 
detection was developed by Barber et al. in 1974 ^Veyman AE, 1994). It allowed the 
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relationship of the Doppler beam to the long axis of the vessel to be defmed and the vessel 
diameter to be measured. 
Since the aortic flow is the blood that perfuse the systemic circulation, it can provide a 
measure of cardiac output (Fisher DC et al., 1983; Laboritz AJ et al., 1985) which can be 
assessed by multiplying the blood flow velocity and the cross-sectional area ofthe aorta (Fig 13). 
The calculation of blood flow velocity requires the calculation of the area under the Doppler 
signal curve obtained from the aorta. The obtained doppler signal, can be converted to the 
integrated flow velocity (V) using the Doppler equations (Fig.l4): 
V = A f x c/2focos9 
where V is the velocity of the reflecting object, A f is the ultrasound frequency shift, c is the 
speed of sound in the medium, f � i s the frequency of ultrasound used, 9 is the angle of insonance 
between the ultrasound beam and the directional vector ofblood flow. 
The cross-sectional area, which is the other major determinator for the calculation of 
/ 
stroke volume can be measured by M-mode or two dimensional echocardiography. The diameter 
• 
(d) of the aorta is measured at the end of systolic phase, and the cross-sectional area is calculated 
according to the following equation: 
A = 7id' / W 
Stroke volume (SV) can then be determined if the cross-sectional area (CSA) and the blood flow 
velocity time intergral (VTI) at the aorta are known by this equation: 
SV = CSA X VTI 
Finally, cardiac output can be estimated as the product of stroke volume (SV)and heart rate (HR): 
CO = SV X HR 
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Determination of cardiac output by Doppler echocardiography in adult patients was 
proved to be quite accurate when compared with invasive method (Huntsman LL et al., 1983; 
Ihlen H et al., 1984; Vandenbogaerde JF et al., 1986; Elkayam U et al., 1983; Schuster AH and 
Nanda NC, 1984). Li children and newborn babies, a close correlation between cardiac output 
determined by Doppler echocardiography and invasive methods was also repeatedly observed 
(Alverson DC et al., 1982; Rein AJJT et al, 1986; Walther FJ et al., 1985; Goldberg SJ et al., 
1982; Sholler GF, Whight CM and Celermajer JM，1986). Walther et al reported the normal 
range of Doppler-derived cardiac output to be 200-325 mL/min/kg in a group of 59 preterm 
infants and 62 term infants. 
The potential sources of error in the technique included the angulation of the transducer, 
the inaccurate measurement of the aortic cross-sectional area and aortic flow velocity. Firstly, 
from the Doppler equation, ifthe angle 0 is 15° or less, the cosine is closed to one and can be 
ignored. If the angle is greater than 15° to the axis of aortic blood flow, there would result in 
underestimation of the time velocity (Alverson DC et al., 1982; Tibballs J et al., 1988). 
•j I 
Secondly, the accurate measurement of the aortic diameter is important since it directly * 
influences the estimation of the cross-sectional area. It can be performed by using the M-mode 
echocardiography or the two dimensional echocardiography. The calculation of cross-sectional 
area are based on the assumption that the aorta is circular and does not change during systole. 
Several investigators compared measurements at different sites including the left ventricular 
outflow tract, the sinuses ofValsalva and the aortic annulus (Fig.l5) and showed that the annulus 
diameter remained unchanged during systole (Ihlen H et al., 1984; Rein AJ et al., 1986; 
Gussenhoven WJ et al, 1983) and measurements taken at this site agree more closely with 
invasive techniques than at the aortic root (Ihlen H et al., 1984; Rein AJ et al., 1986). The area of 
aortic root diameter, however, changed by approximately 10% during the cardiac cycle (Ihlen H 
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et al., 1984). Although the leading edge technique (outer edge of anterior wall to inner edge of 
posterior wall) has been recommended by the American Society of Echocardiography for the 
purposes of uniformity among echocardiographers (Sahn DJ et al., 1978), Tibballs stated that this 
did not seem to be appropriate for the measurement of flow within the vessel where the internal 
diameter would be preferred (Tibballs J et al., 1988). Ihlen described his studies that the leading 
edge technique may lead to a diameter l-2mm greater than the internal diameter measurement 
although it agreed well with an invasive technique (Ihlen H et al., 1984). Mellander also 
suggested that the trailing to leading edge (internal) diameter should be used for the calculation of 
volumetric flow in infants and children since the addition of the thickness of the anterior aortic 
wall to the diameter over which flow occurred would introduce a significant error (Mellander M 
etal, 1987). -
Thirdly, problem may arise with the measurement of the aortic flow velocity using pulsed 
doppler or continuous doppler echocardiography. The pulsed doppler echocardiography allows 
insonation of flow velocity by range-gating at a specific location but with a limited maximal 
detectable velocity. In contrast, the continuous doppler echocardiography measures velocity 
along the entire beam path with no limits to detectable velocity but with no range resolution. It 
may give a misleading mean spatial velocity and the other vessels nearby can also be insonated 
O^ihoyannopoulous P, 1993). In order to have an accurate measurement ofblood flow velocity, it 
is important to note that the location of velocity measurement should be the same as that for 
aortic cross-sectional area. The pulsed doppler echocardiography rather than continuous doppler 
echocardiography is preferred. This is especially so when serial of measurements is needed since 
the position of the sample volume is known and can be fixed (Tibballs J et al., 1988). 
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2. Thoracic electrical bioimpedance 
Thoracic electrical bioimpedance (TEB), or impedance cardiography, is a noninvasive 
method for the measurement of blood flow. This technique continuously tracks the beat to beat 
changes in left ventricular stroke volume (SV). The location and distribution of blood lead to 
changes in impedance. Since the distribution of blood in the chest is changed primarily by the 
amount ofblood in the heart which varies with systole and diastole, thoracic impedance changes 
should be directly related to the cardiac stroke volume (Durbin CG, Jr., 1995). Cardiac output is 
calculated as the estimated stroke volume multiplied by heart rate. 
Despite the presence ofcardiac shunts, cardiac output measured by impedance is found to 
give representative values for systemic blood flow in children when compared with values 
determined by the Fick technique (Miles DS et al., 1989). In the presence of aortic valvular 
insufficiency and ventricular septal defects (left to right shunts), impedance-derived cardiac 
output produces overestimation of systemic output (Lababidi Z et al., 1971). This technique also 
have some technical difficulties，for example, poor patient acceptance due to the placement of 
dual circumferential band electrodes on the neck and lower thorax (Penney BC, Patwardhan NA 
and Wheeler HB, 1986), and the maintenance of the carotid upstroke recording in the critically ill 
patient (Durbin CG, Jr., 1995). 
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L6Methods of oxygen consumption measurements 
The rate at which the processes of aerobic metabolism took place can be assessed by 
measuring the rate of oxygen consumption (VO2) and carbon dioxide production (VCO2). The 
importance of oxygen consumption in meeting the requirements of body metabolism has been 
recognized since the early research of Pfluger in the early 1872 (Pfluger E, 1872). Changes in 
oxygen consumption were first described by Cuthbertson in 1936 in trauma patients (Cuthbertson 
DP, 1936). Later Guyton showed that the degree of reduction in oxygen consumption was related 
to survival or death (Guyton AC, 1959). Shoemaker et al. also showed that therapy based on 
improving VO2and oxygen divery (DO2) could reduce the morbidity and mortality in critically ill 
patients (Shoemaker WC et al., 1988). However, treatment based on oxygen consumption and 
oxygen delivery was not commonly practiced until the introduction of the Swan-Ganz catheter 
into therapy in 1971 (Ganz W et «/,1971). 
Oxygen consumption can be measured at the bedside by either using the Fick principle or 
the indirect calorimetry described as follows: 
1. The Reverse Fick equation 
The Fick principle can be applied to determine VO2. Techniques for measurement of 
VO2 were developed in healthy volunteers and remained the gold standards ofaccuracy (Haldane 
JS,1920; Van Slyke DD and Neill JM, 1924). After the introduction ofthe balloon floated Swan-
Ganz catheter (Ganz W et al., 1971), invasive measurement ofVO2 has become relatively easy to 
perform in the operating room and the intensive care unit. As described in the previous 
paragraphs, the standard Fick equation described by Fick in the 1880s originally is as follows: 
Q = VO2/(CaO2-CvO2) 
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where Q is cardiac output, (CaO2 - CvO2) is the arteriovenous oxygen content difference. 
After rearranging the equation, oxygen consumption (VO2) can by calculated as: 
VO2= (CaO2 - CvO2) X Q (mL / min) (Little RA and Edwards JD, 1993) 
It is an invasive measurement that an indwelling pulmonary artery catheter is required to 
determine the cardiac output (by thermodilution). It also requires arterial and mixed venous 
blood sampling. The results are not immediately available since it requires complex calculations 
and the blood probes have to be analyzed for oxygen concentration (Hankeln KB, 1993) 
Potential error may arises from the measurement of cardiac output, haemoglobin, and blood gas 
determinations. 
2. Indirect calorimetry 
The basic principle ofall bedside indirect calorimetry systems is to determine the oxygen 
consumption (VO2) and the carbon dioxide production (VCO2) per unit of time by the patient. 
The indirect calorimetry technique is non-invasive, which includes two different kinds of 
technique, the closed-circuit technique and the open-circuit technique. 
a) Closed - circuit technique 
The key components of the closed circuit calorimeter are a volumetric spirometer, a 
mixing chamber, a CO2 analyzer and a CO2 absorber (Fig.l6). The spirometer is filled with a 
known volume of O2 and is connected to the patient. With inspiration, volume is drawn from the 
spirometer to the patient, and a portion of oxygen is consumed. Gas from the patient flows into 
the mixing chamber and a sample is taken for analysis of expired carbon dioxide fraction 
(FECO2). The carbon dioxide (CO2) produced is removed by passing the expired gas through a 
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CO2 absorber, and the remaining gases retum to the spirometer. The volume loss from the system 
as recorded by the spirometer over time is the VO2 (Hess DR and MundroffJ, 1992). 
This technique can also be applied to mechanically ventilated patients with the use of a 
bag-in-the-box bellows chamber to the breathing circuit (Fig.l7). The bellows is pressurized by 
the ventilator, resulting in ventilation of the patient. The decrease in the circulating gas volume is 
detected by an ultrasonic sensor and the oxygen is automatically replaced from an external 
oxygen supply (Hankeln KB, 1993). 
The major advantage ofthe closed circuit method is its ability to make measurements at 
high F1O2 levels (up to 1.0) (Hess DR and Mundroff J, 1992). However, there is a risk of CO2 
rebreathing and also the errors due to circuit leaks (Durbin CG, Jr.，1995). Using this technique, 
Lubble found a correlation of 0.97 to invasively measured VO2 in post-operative cardiovascular 
patients (Liibble N et al., 1989). 
b) Open - circuit technique 
In open - circuit technique, oxygen and carbon dioxide concentrations are measured in 
samples of inspired and expired gases. The key components ofan open circuit calorimeter are the 
oxygen and carbon dioxide analyzers, a volume measuring device and a mixing chamber (Fig.l8). 
This technique was first applied clinically in 1978 by Neuhof and Wolf OSfeuhof H and 
WolfH, 1978) allowing non-invasive measurements of VO2 at the bedside. This technique can 
be used either in spontaneously breathing patient and those requiring mechanical ventilation. It 
remains the most widely used technique since it is easier to adapt to ventilator circuits than the 
closed circuit technique. 
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Unlike the closed - circuit method, the patient inhales ambient air that has a constant 
composition. During inspiration, the patient's inspiratory gas is sampled for the measurement of 
oxygen (F1O2) and carbon dioxide (F1CO2) concentration. Before discharging the expiratory gas 
into the ambient atmosphere from the mixing chamber，re-analyze and measure its concentration 
and volume. The mixing chamber is used to create a stable mean concentration of expired 
oxygen and carbon dioxide. Concentrations of gases can be determined by infrared carbon 
dioxide and oxygen analyzers. After the measurement of the inspired and expired oxygen, carbon 
dioxide, and the volume ofexpired gas, oxygen consumption (VO2) can be determined as: 
VO2= (Wi X F1O2) - (VE X FEO2) (Ritz R, Cunningham, 1993 ) 
where V1 is the inspired volume, F A is the inspired O2 fraction and Ve, FEO2 are, respectively, 
the expired volume and expired O2 fractions. Carbon dioxide production (VCO2) can also be 
calculated: 
VCO2=( VE X FECO2) - (Vi X F1CO2) 
FECO2 represent the expired CO2 fraction whereas F1CO2 represent the inspired CO2 fraction. 
F1CO2can be negligible since it is less than 0.03 % when breathing room air and should be zero in 
a ventilator circuit (Hess DR and Mundroff J, 1992)，hence: 
VCO2= VE (FECO2) 
In addition, inspiratory minute ventilation measurements are not done by most calorimeters 
However, by assuming Vi is equal to Vs, there should be an error of 15 to 20 % in VO2 
measurement result (ifRQ is 0.8) (Hess DR and MundroffJ, 1992). The Haldane transformation 
must be used if Vi is not measured. It permits calculation of Vi from the measured Ve by means 
of the nitrogen fraction in inspired (F1N2) and expired gas (FEN2) (Hess DR and Mundroff J, 
1992): 
V l = ( F E N 2 / F 1 N 2 ) X ( V E ) 
then VO2 can be estimated as: 
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VO2= {( FEN2/ F1N2) (F1O2) - FEO2} X VE 
The nitrogen O^ 2) concentration is usually determined by assuming no other gas is present in the 
sample other than O2, CO2, and N2. So the concentration of expired and inspired N2 can be 
estimated as: 
FEN2=l-FEO2-FECO2 
F1N2= 1-FA - F1CO2 
Consequently, the equation for calculation of VO2 is as follow and it is employed by most 
manufactures of open - circuit calorimeters: 
VO2={(l-FEO2-FECO2) / ( l - F A ) } X (FA-FEO2) X CV^ E) (DurbinCGJr.,1995) 
When applying this technique, it has been suggested that F1O2 must remain stable to be 
within 土 0.005 % (Browning JA et al., 1982) and the volume of F1O2 must be less than 0.6 
(Ultman JS and Bursztein S，1981). Otherwise it may result in inaccurate VO2 measurement. In 
patients who are breathing spontaneously, this is a very simple and accurate method of indirect 
calorimetry. However, when applied to those patients who are ventilated, the F1O2 delivered to 
the patient varies by 土 1 to 2 % oxygen per breath (Durbin CG Jr., 1995). In addition, it requires 
precise analysis of the oxygen content of the patient's inspired and expired air by appropriate 
sensors (Hankeln KB, 1993). The effects of humidity, production of mucus and salivation and 
the mixture of gases may influence the properties of the sensor (Hankeln KB, 1993). 
A dilution technique was suggested by Merilainen (Merilainen PT, 1987) and Takala et 
ol. CTakala J et al. 1989) which avoids potential problems with flow sensors. The Datex Deltatrac 
metabolic monitor, which is used in our study, is based on this gas dilution principle instead of 
standard measurement of flow. It allows direct differential measurement of the difference 
between inspired and expired oxygen concentrations, and the option to study spontaneously 
breathing patients with a canopy system (Takala J et al., 1989). 
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In spontaneously breathing patients, sample of the inspired gas is taken before its entering 
into the canopy (Fig. 19). The mixed expiratory gas in the canopy is drawn by a known, constant 
rate off low controlled by a constant flow generator. A fast - response, paramagnetic differential 
oxygen sensor (OM-101, Datex / Instrumentarium ) (Merilainen PT, 1988) with automatically 
compensated baseline drift and a infrared CO2 sensor are used to measure the concentration of 
gases. Sample of the expired gases is taken before the gas is discharge to the air. With the 
canopy, VO2 is calculated using the Haldane transformation: 
VO2={Q/(l-F1O2)} X {(F1O2-FEO2)-F1O2 X (FEC02-FiC02))(Merilainen PT, 1988) 
where Q is the constant flow. During mechanical ventilation (Fig. 20)，connection is made to the 
outlet port of the ventilator and expired air is collected through a mixing chamber. The gas is 
drawn from the room instead of the canopy. Samples of the inspired and expired gases, 
respectively, are taken from the ventilator's inspiratory limb and from the mixing chamber. 
Respiratory quotient (RQ) is estimated with the Haldane transformation: 
RQ = ( 1 - F A ) / {(F1O2-FEO2) / FECO2 - ( F A ) } (Merilainen PT, 1987) 
Hence the VO2 is calculated from the RQ as: 
VO2 = VCO2/RQ 
In both the canopy and respiratory mode, VCO2 is estimated as: 
VCO2 = Q X FECO2 
Since the air is drawn through the canopy, the risk of errors by leaks during the canopy 
measurement in clinical use is relatively small. It has been demonstrated that this is a valuable 
method for clinical application in pediatric unit (Weyland W et a/.,1994) and the newborn infants 
whose weight more than 1000 grams (Shortland GJ, Fleming PJ and Walter JH, 1992). However, 
in small preterm infants with their very low oxygen consumption and carbon dioxide production, 
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breath sampling is more difficult since the sampling flow must be low to prevent excessive 
dilution of expired air (Shortland GJ, Fleming PJ and Walter JH, 1992), and a low sampling flow 
will increases the risk of incomplete gas sampling and underestimation of oxygen consumption 
and carbon dioxide production (Bauer K et al., 1997). Bauer K et al. also stated that the canopy 
breath sampling systems needed a high flow rate and is not suited for measurements in preterm 
infants less than 1500 grams (Bauer K etal., 1997). 
From the ventilator mode, limitations include the possible loss of expired gas from 
around the endotracheal tube. Applications of the cuffed and noncuffed endotracheal tube had 
been compared by many investigators and their opinions were quite different. Reynolds et al. and 
Smith et al. showed that there was no significant difference in the frequency rate of 
postextubation stridor (Reynolds GE et al., 1989; Smith PG and Blumer JL, 1989). However, 
Uejima believed that the use of cuffed endotracheal tube was likely to induce tracheal injury and 
postextubation croup (Uejima T, 1989). Hence the cuffed endotracheal tube is not popularly used 
in infants. The use of noncuffed endotracheal tube, however, may sometimes resulted in 
unavoidable leaks (Lucas A, Norhia V and Roberts SB, 1987). In order to correct for all ofthe 
expired gas for accurate measurement，it is important to avoid the airleak around the endotracheal 
tube. Chwals WJ et al demonstrated that VO2 determined by indirect calorimetry may be reliable 
in infants and children with the use of a noncuffed endotracheal tube if no audible airleak is 
detected (Chwals WJ, Lally KP and Woolley MM, 1992). However, no such data existed in 
premature babies. 
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i. 7Haemodynamic effects ofred blood cell transfusion in premature infants 
When hypoxia occur, compensatory mechanisms including the increase in heart rate or 
even the increase in cardiac output may be switched on. After red blood cell transfiision, the 
elevated heart rate and cardiac output are expected to retum to normal. 
Several investigators have studied the haemodynamic effects ofred blood cell transfusion 
in preterm infants. The results however were conflicting. Three groups ofinvestigators reported 
a decline in cardiac output after transfusion. In Lachance's study, 12 symptom-free preterm 
babies who were breathing spontaneously were studied. They had a postnatal age ranged from 4-
to 8-week-old. Cardiac output decreased significantly with a decrease in heart rate 36-48 hours 
after transfusion of packed red blood cells. There were no significant changes in left ventricular 
function and basal metabolic rate after transfusion (Lachance C et al., 1994). Nelle et al 
conducted a similar study in 33 stable preterm infants. All ofthem were breathing spontaneously 
with a postnatal age of three weeks or older. Cardiac output decreased significantly 4 hours after 
transfusion due to the decrease in heart rate and stroke volume. Vascular hindrance and blood 
viscosity increased significantly after transfusion CNelle M et al., 1994). Hudson studied 24 
preterm infants with a postnatal age ranged from 2 - 90 days. Ten ofthem were ventilated, four 
were given supplementary oxygen, and ten were breathing in air. Cardiac output decreased 
significantly 12 - 24 hours after transfusion (Hudson I et al., 1990). In Lachance's and Hudson's 
study (Lachance C et al., 1994; Hudson I et al.，1990), the amount of packed red blood cell 
transfused was at a mean value of 22.5ml/kg and 30ml/kg respectively while in Nelle's study 
lOml/kg of packed red blood cell was transfused 0^e11e M et al., 1994). The post-transfusion 
hemoglobin level of the infants in the three studies were 15 gm/dl, 17.7 gm/dl and 12 2 gmAil 
respectively. 
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Contrary to the above observations, unchanged cardaic output after transfusion was 
reported by two other groups of authors. Alverson et al. measured the transfusion effect on 
cardiac output aiid oxygen consumption in 10 premature infants with a postnatal age ranged from 
3- to 8-week-old. Nine of them required mechanical ventilation. Oxygen consumption fell 
significantly 24 hours after the transfusion, but there was no significant decrease ofcardiac output 
(Alverson DC et al.，1988). Similarly, Bifano et al. studied the cardiac output and oxygen 
consumption in 14 preterm infants who were breathing room air with a postnatal age greater than 
4 weeks. They also reported that inspite of significant decrease in heart rate and oxygen 
consumption, there was no significant change of cardiac output 8 to 12 hours after transfusion 
(Bifano EM, 1992). However, the quantity of packed red blood cell transfused to the infants in 
both studies was 10 ml/kg only and the magnitude of increase in post-transfusion haemoglobin 
level was much smaller in these two groups of infants in comparison to the above discussed three 
groups of infants. It is likely that the non-significant change of cardiac output was due to the 
smaller change in haemoglobin level. Notably，in both studies, cardiac output did show a 
download trend after the transfusion, and this is in line with the changes of heart rate and oxygen 
consumption. The small case number may also have contributed to non-significant changes of 
cardiac output. 
In four of the five studies the postnatal-age of the infants were greater than 3 weeks. 
Data of the traiisfusion effects on cardiac output in preterm infant whose postnatal age was less 
than three weeks remain scanty. 
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Section 2 Introduction 
Oxygen is important to tissue to maintain the energy production required for cell function 
and growth. It is transported by binding to the haemoglobin in the red blood cells. 
Anaemia may lead to cellular hypoxia and is common in premature babies in the neonatal 
intensive care unit. This is usually a result of blood loss due to phlebotomy, the physiologic 
anaemia of prematurity, infection, haemolysis, occult haemorrhage prior to birth, obstetric 
accidents and internal haemorrhage. In sick premature infants with severe respiratory disease, 
frequent blood sampling for laboratory studies is usually required. The mean volume of blood 
removed for sampling has been reported to range from 0.8 to 3.1 ml/Kg per day during the first 
few weeks of life for premature infants requiring intensive care G^exo E, Christensen NC and 
Olesen H, 1981; Obladen M, Sachsenweger M and Stahnke M, 1988). Blood loss caused by 
phlebotomy has been shown to be the most common cause for red blood cell transfusions in 
neonatal patients (Lenes BA and Sacher RA, 1981). It is customary to maintain the haematocrit 
above 40 per cent regardless of the quantity of blood drawn for testing (Strauss RG, 1994) 
Physiological anaemia of prematurity is also common. All infants will experience a decline in 
haemoglobin concentration in the first one to three months of life due to reduction in red blood 
cell production, rapid destruction of red blood cells, and the expansion of blood volume with 
growth. At birth, 60-80% ofhaemoglobin is fetal haemoglobin which has higher oxygen affinity 
than the adult haemoglobin and makes oxygen release from the blood to the tissue more difficult 
(Anselmino KT and Hoffman F, 1930). It takes about six months for the replacement ofHb F by 
Hb A. Although this kind of "physiologic anaemia of infancy" is self-limited, symptoms and 
signs may develop in those sick premature babies and transfusion of red blood cells may also be 
required. 
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In order to maintain adequate oxygen supply in an anaemic state, compensatory 
mechanisms may be switched on. These include the increase in heart rate and cardiac output, the 
higher oxygen consumption and increased production of erythropoietin. Previous studies have 
shown that heart rate and cardiac output fell to normal levels after transfusion (Alverson DC 
Isken VH and Cohen RS, 1988; Stockman JA III, 1984); higher oxygen consumption and high 
oxygen extraction ratios, which also fell after transfusion (Alverson DC, Isken VH and Cohen 
RS，1988; Alverson DC etal,, 1984; Lachance C etal., 1994; Stockman JA III, 1986). There was 
also increased production of erythropoietin. However, the erythropoietin response in preterm 
infant was less prominent when compared to adults (Browm MS et al., 1984). The decreased 
responsiveness to available oxygen was inversely related to the infant's level of maturity 
(Alverson DC, 1995). 
For the treatment of anaemia, red blood cell transfusion can increase the red cell mass 
and haemoglobin rapidly. It remains the most commonly used method. It is usually beneficial, 
but one must consider the possibilities of: inhibition ofnormal endogenous erythropoiesis; graft, 
versus-host disease (GVHD); haemolytic transfusion reaction; fluid overload; electrolyte and 
acid-base imbalances; immunosuppression; and the transmission of infectious agents. Thus the 
decision of whether to transfuse or not is sometimes debatable. Recently, the use of recombinant 
human erythropoietin has been shown to be effective in reducing the number of transfusions 
required in the management of infants (Shannon KM et al., 1995). But adverse effects ofits use 
such as early mortality or neutropenia and an increased risk ofcot death have also been reported 
OVilliamson P, 1996; Emmerson A，1993). 
Until now there is no consensus about the criteria for neonatal transfusions. Transfusion 
is usually given for the replacement of blood loss and for those patients with the signs and 
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symptoms such as periodic breathing，apnea, decreased activity, lethargy, poor feeding, and poor 
weight gain. Multiple transfusions are often required over a period of weeks (Obladen M, 
Sachsenweger M and Stahnke M, 1988) in sick infants. It is not uncommon for them to be 
transfused with a cumulative volume of red blood cells exceeding their own blood volume and to 
be exposed to multiple donors (Sacher RA, Luban NLC and Strauss RG，1989). 
Conflicting results have been reported regarding the haemodynamic effects oftransfusion 
in preterm infants. Some investigators reported that there is a reduction in cardiac output after 
red cell transfusion (Hudson I et al., 1990; Lachance C et al., 1994; Nelle M et al., 1994) while 
two other studies did not show any significant changes (Alverson DC, Isken VH and Cohen RS， 
1988; Bifano EM, Smith F and Borer J, 1992). However, the studies which showed no changes 
were limited by the lack of power with only ten (Alverson DC, Isken VH and Cohen RS, 1988) 
and fourteen infants (Bifano EM, Smith F and Borer J, 1992) examined. 
Investigators have also demonstrated conflicting results regarding the effect of 
transfusion on oxygen consumption in anaemic infants (Lachance C et al., 1994; Bifano EM 
Smith F and Borer J, 1992; Stockman JA III and Clark DA, 1984). While Bifano (Bifano EM, 
Smith F and Borer J, 1992) and Stockman (Stockman JA III and Clark DA, 1984) had shown a 
decline in oxygen consumption after red cell transfusion, Lachance (Lachance C et al., 1994) had 
shown the opposite. 
In view of the conflicting reports about the effect of red blood cell transfusion on 
ventricular output and oxygen consumption, my two studies were designed to investigate the 
acute effects of red blood cell transfusion on 1) the left ventricular output, and 2) the oxygen 
consumption, of the anaemic preterm infant in the neonatal ICU. 
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Section 3 Methodology 
The study was approved by the Ethics Committee for Clinical Research ofthe Chinese 
University ofHong Kong. Preterm infants admitted into the neonatal unit were enrolled ifthey 
required red blood cell transfusion and who fulfilled the following criteria: 1) gestation< 36 
weeks; 2) postnatal age< 4 weeks; 3) haematocrit< 40% in both part ofthe studies; 4) weighing 
more than 1000g (Shortland GJ, Fleming PJ and Walter JH, 1992) in the second part ofthe study. 
Infants with the following conditions were excluded: 1) unstable condition requiring frequent 
adjustment of the ventilator settings; 2) congenital heart lesion; 3) patent ductus arteriosus which 
was routinely checked by echocardiogram and colour-doppler study before the enrollment; and 4) 
echocardiographic evidence of persistent pulmonary hypertension with right to left shunt. 
Informed parental consents were obtained before the investigation commence. 
Decision on transfusion of red blood cells was made by the attending neonatologists who 
were not aware of the nature of the study. As a unit policy, transfusion was considered indicated 
when the accumulated volume ofblood sampling exceeded 10% ofthe baby's blood volume, or 
when haematocrit fell below 40% in the presence ofacute respiratory distress or when there were 
signs of anaemia such as tachycardia, apnea, increase in oxygen requirement, or failure to gain 
weight. Each transfusion consisted of 10-15 ml/kg packed red blood cells given intravenously 
over 3 • 4 hours. Frusemide 1 mg/kg was given to all infants halfway during the transfusion 
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Part L Cardiac output study 
Echocardiogram was carried out one hour before commencement of transfusion. It was 
repeated one hour & 24 hours after transfusion was completed. The procedure was performed 
using an Acuson 128 x p /10 ultrasound scanner with a 7 Mhz probe (Fig.20) while the infant was 
asleep or he/she was in a quiet but alert state. Two-dimensional echocardiogram was obtained by 
scanning along the parasternal long-axis to determine the internal aortic diameter at the aortic 
armulus (Rein AJ et al., 1986) (Fig.21). The aortic cross sectional area (CSA) was calculated 
according to the formula: CSA = 7tdV 4 cm^ where d = diameter ofthe aorta. The average of 
three measurements of aortic diameter was taken for the calculation ofcardiac output. 
Aortic blood flow velocity (V) was measured from the pulsed-wave Doppler signals 
(Fig.22) obtained from the suprasternal view of the ascending aorta (Fig.23) (Alverson DC, 
Isken VH and Cohen RS, 1988), using the following equation ： 
V = Af X c / 2 f o C o s 9 , 
Where Af^ change in frequency, c = sound velocity in the blood , f �= transmitting frequency 
and e = the angle between the ultrasound beam and the direction ofblood flow (Alverson DC et 
al., 1982). The highest signals obtainable were recorded for the computation of stroke volume 
(SV), which is the product of multiplying the average time velocity integral by aortic cross 
sectional area: 
t=LVET 
SV = C S A Z V A t , 
t=0 
where t = sampling interval (in seconds), LVET = left ventricular ejection time (in seconds). 
Left ventricular output (CO) was calculated as stroke volume times heart rate, (C0= SV x 
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HR), and cardiac index (CI), was calculated by dividing the cardiac output by body surface 
area. 
Left ventricular systolic function was assessed by M-mode echocardiography taken at 
the level of the chordae below the mitral valve using the parasternal long - axis view (Fig.24). 
The left ventricular end-systolic dimension (EDS), left ventricular end-diastolic dimension (EDD) 
and the posterior wall thickness in systole (LVPWS) and diastole (LVPWD) were measured. The 
ejection time (LVET) was measured on the M-mode tracing ofthe aortic valves from the opening 
to the closure ofthe valves (Fig.25). For each parameter, measurement was obtained from three 
consecutive beats and the average calculated. The fractional shortening (FS) = [(EDD - EDS) / 
EDD]，and the ejection fraction (EF) = [(EDV - ESV)/EDV x 100], was calculated automatically 
by the computer. 
Before and after transfUsion, blood pressure was monitored continuously while arterial or 
capillary blood gas was measured at 4 hourly interval. Venous haemoglobin and haematocnt 
were estimated before and 24 hours after transfusion. Systemic red cell transport was calculated 
as cardiac output times haematocrit 0^e11e M et al., 1994). 
Paired t-test was used to compare the variables before and after transfusion. Cardiac 
index (CI) instead of cardiac output was used for the analysis in this study so as to avoid the 
variations of size and weight between patients. Mixed-effects regression model (Hedeker D and 
Gibbons RD, 1996; Goldstein H, 1995; Bryk AS and Raudenbush SW, 1992) was performed 
using the MIXREG computer software (Hedeker D and Gibbons RD, 1996) based on the EM 
alogrithm and a Fisher-scoring solution to determine whether various factors such as haematocrit, 
gestational age, postnatal age, sex and blood pressure affected the cardiac mdex. Essentially, 
mixed-effects regression model is an extension of ordinary multiple regression model, taking into 
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account the between-subject heterogeneity. For longitudinal data, mixed-effects regression model 
allows for measurements made at different ages and at unequal intervals, and with varied number 
of measurements (Hedeker D and Gibbons RD, 1996). 
Part 11. Oxygen consumption study 
Metabolic measurements including oxygen consumption(VO2), carbon dioxide 
production(VCO2), respiratory quotient(RQ) and energy expenditure(EE) were measured one 
hour before the commencement of transfusion and were repeated one hour and 24 hours after the 
transfusion was completed. The investigation was performed with a Deltatrac 11™ metabolic 
monitor，(Deltatrac II™; Datex>anstrumentarium, Helsinki, Finland) an open-system indirect 
calorimetry (Fig.26). Before each measurement, Deltatrac II™ was calibrated as suggested by 
the manufacturer, 
hi those spontaneously breathing babies (Fig.l8), their heads were placed under the 
canopy provided and the expired gas was captured by a constant airflow drawn through the 
canopy to the gas analyzers. Concentrations of carbon dioxide and oxygen were measured in 
both the ambient room gas entering the canopy and in the gas leaving the canopy by an infrared 
carbon dioxide sensor and a paramagnetic differential oxygen sensor through a sample line 
(Shortland GJ, Fleming PJ and Walter JH, 1992). VO2 was calculated from the difference 
between inspired and expired values with a known constant flow rate(Q) using the Haldane 
transformation with: 
VO2={Q / ( l - F A ) } X {(FA-FEO2) - F A X (FHCO2 X F1CO2) (Merilainen PT, 1988) 
where Q is the constant flow, F1O2 is the concentration ofinspired oxygen, FEO2 the concentration 
of expired oxygen, F1CO2 the concentration of inspired cardon dioxide and FECO2 the 
concentration of expired carbon dioxide. 
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In the ventilated infants (Fig.l9), connection was made to the outlet port ofthe ventilator 
and the expired gas was collected through a mixing chamber. The gas was drawn from the room 
and the sample of the inspired and expired gases were taken from the ventilator's inspiratory limb 
and from the mixing chamber. With the use ofHaldane transformation, respiratory quotient (RQ) 
was estimated as: 
RQ= ( l - F A ) / {(F1O2-FEO2) / FECO2-(F1O2)} (Merilainen PT, 1987) 
And the VO2 was calculated from the RQ as: 
VO2=VCO2/RQ 
The carbon dioxide production (VCO2) was estimated in both canopy and respiratory mode as 
follows: 
VCO2= Q X FECO2 
The monitor displayed the average values ofVCO2, VO2, RQ, and EE in every minute, and at the 
same time, data were transferred to a computer. Data obtained from five minutes to 30 minutes 
after the investigation started were used for further analysis. 
Blood pressure, arterial or capillary blood gas were recorded before and after transfusion. 
Venous haemoglobin and haematocrit values were estimated before and 24 hours after 
transfusion. The statistical evaluation was performed using paired t-test to detect changes of 
measured variables after transfusion. Mixed-effect regression model was performed to determine 
if the oxygen consumption was affected by haematocrit or other confounding factors. 
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Section 4 Results 
/. Cardiac output study 
This part of the study was conducted from May 1996 to Feb 1997. 75 preterm babies 
were recruited. Serial investigations were completed in only 62 cases. The changes in clinical 
conditions in some infants rendered them unsuitable for further studies. Data of another 5 babies 
could not be used for analysis because the respiratory mode of these infants changed during the 
period of study. As a result, only 57 data could be used for analysis. 
In our study group, premature babies (22 female, 35 male) had a mean gestational age of 
28.8 weeks (range 23.1 to 34.3) and a mean postnatal age of 14.0 weeks (range 1 to 29). Each of 
them had received a mean volume of 14.8 ml/kg packed red blood cells. The range oftransfused 
volume was between 12.4 mVkg to 15.8 ml/kg (Table 1). Haematocrit was raised from a mean of 
34.5(4.2)% (SD) to 41.7(4.2)% after transfiision. Univariate analyses using paired t-test showed 
that most of the parameters did not change an hour after transfusion, only the blood flow velocity 
(VTI) and the left ventricular ejection time (LVET) decreased significantly (p<0.05). Significant 
decrease in VTI of the aorta was found 24 hours after the transfusion (p=0.002). Cardiac index 
was also decreased by an average of 8.7% from a mean 2.29(0.62) (SD) 1/min to 2.1(0.63) L/min 
24 hours after transfusion (p=0.023). Systemic red cell transport increased by an average of 
11.1% from a mean 0.09(0.03) (SD) to 0.1(0.02) 24 hours after transfusion(p=0.00001). There 
were no significant change in heart rate, systolic (SBP) and diastolic (DBP) blood pressure, 
concentration of the inspired air (F1O2), left ventricular shortening fraction (FS) and ejection 
fraction (EF) 24 hours after the red cell transfusion (Table 2). 
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Multivariate analysis using the mixed-effects regression model was performed to 
determine whether and how various factors such as haematocrit, gestational age, postnatal age, 
blood pressure and sex affected cardiac index. Only haematocrit and sex were showed to affect 
the cardiac index (Table 3). For each one percent increase in haematocrit, cardiac index would 
decrease by 0.03 l/miny'M^ body surface area. Besides this，cardiac index for female was 0.378 
l/miny'M^ body surface area lower than that of male. There were no significant correlation 
between cardiac index and gestational age, postnatal age and blood pressure. 
II. Oxygen consumption study 
This part of the study was conducted during the period from March 1997 to August 1997. 
13 preterm infants were studied. Serial accurate measurements were only completed in 10 cases. 
They had a mean gestational age of 29.6 weeks (range 17.1 to 34.4) and a mean postnatal age of 
33.6 days (mean 5 to 89 days) (Table 4). All of them were breathing spontaneously. Clinical 
picture remained unchange during the period of investigation. A mean volume of 14.99 mVkg of 
packed red cell was transfused to the babies. The range of transfused volume was between 
14.35ml/kg to 20.3ml/kg. At the time of the study, their mean weight was 1.59 Kg. Other data 
were summarized in Table 5. Paired t-test showed that haematocrit increased by an average of 
18.9% after transfusion. Heart rate decreased from a mean 149.89 (8.57) (SD) bpm to 138.22 
(16.53) bpm (p<0.05). Respiratory rate, systolic and diastolic blood pressure did not change 
significantly between recordings. There were neither significant changes of carbon dioxide 
production (VCO2), oxygen consumption (VO2), respiratory quotient (RQ), nor of energy 
expenditure (EE) (P>0.05). Since there was only a few cases studied, the multivariate analysis 
procedure could not be performed. 
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Several problems arose when we recruited the cases. Firstly, it was related to the 
ventilators used in our unit. We had several types of ventilators in our unit, but it seemed that 
only one of them was available for accurate measurement since there was dilution of expired gas 
which occured at the expiratory outlet of other ventilators. 
We tried to connect the metabolic monitor to two ventilated infants to that avaliable 
ventilator. But the minute-by-minute results showed on the screen suggested that an error had 
occurred. Oxygen consumption value remained very low and even negative value came out. 
This could be related to the F1O2 required by the infants. One of the infants required maintaining 
ofF1O2 over 0.6. For accurate measurement ofVO2 by open-circuit indirect calorimetry, Ultman 
stated that F1O2 must be less than 0.6 (Ultman JS and Bursztein S, 1981). Takala et al. also 
demonstrated the VO2 measurement by the Deltatrac metabolic monitor and stated that the 
accuracy of this system was maintained up to F1O2 0.6 (6% error), but was reduced at F1O2 
0.8(16% error) (Takala J et al., 1989). We had tried to adjust the F1O2 level delivered to that 
baby, however the lower level of F A could not be tolerated by the baby. In the second baby， 
F1O2 was below 0.6, but the result was similar to the first baby. We considered that the 
possibility of the inaccuracy in measurement might be due to the air-leakage around the 
endotracheal tube. We then pressed gently over the tracheal for several minutes, and the level of 
VO2 in this several minute raised to a much higher level. After this, we released the pressure and 
the VO2 level fell again. 
Since it is difficult to recruit cases, we also tried to measure VO2 of an infant breathing 
spontaneously with his weight of 930 grams. The pre-transfiision value of VO2 seems to be 
accurate. However, VO2 decreased after transfusion and this very low level of VO2 and VCO2 
could not be measured accurately. The sampling of gas in the canopy mode required a high 
sampling flow in order to collect the complete expired gas. However, in small infants, the 
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sampling of gas became more difficult since the high flow rate could lead to dilution of expired 
air (Bauer K et al., 1997). As a result, this data could not be used for analysis. 
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Section 5 Discussion 
L Cardiac output study 
Potential sources of errors in serial echocardiographic measurement of cardiac output 
include inconsistent angulation of the transducer during measurement of the aortic cross 
sectional area and aortic flow velocity. From the Doppler equation, it can be understood that if 
the angle G is 15° or less, the cosine is closed to one and can be ignored. Investigator must 
adjust the image of ascending aorta as parallel to the sound beam as possible to avoid 
underestimation of the time velocity (Alverson DC et al., 1982; Tibballs J et al., 1988). In 
order to obtain more accurate result, measurement of aortic diameter at different sites has been 
suggested by various investigators (Rein AJ et al., 1986; Alverson DC et al., 1982; Walther FJ 
et al., 1985; Welch E et al., 1994). The annulus diameter was used in this study since it 
remained unchange during systole (Ihlen H et al., 1984; Rein AJ et al., 1986; Gussenhoven WJ 
et al., 1983) and had been shown to agree more closely with invasive techniques (Ihlen H et al., 
1984; Rein AJ et al., 1986). Mellander demonstrated that when applying the leading edge 
technique in infants, the addition of the thickness of the anterior aortic wall to the diameter over 
which flow occurred would introduce a significant error (Mellander M et al., 1987). As a 
result, trailing to leading edge (internal) diameter would be preferred in infants for the 
measurement of flow within the vessel (Tibballs J et al, 1988). Pulsed doppler was selected 
since serial measurements at the same location were needed in this study. In the present study, 
comparison was made on repeated measurements on the same baby by the same investigator 
using consistent approach and thus the results were unlikely to have been affected by the 
measuring method. 
52 
Discussion 
The infants with patent ductus arteriosus were excluded from the outset since the left 
ventricular output might be affected by the presence of the ductus OValther FJ et al., 1989). 
Investigators had demonstrated that the cardiac output of the premature babies with significant 
patent ductus arteriosus was higher than that of babies without a patent ductus, and that after 
the closure of the ductus, cardiac output reverted to the level similar to the latter group of 
babies (Shimada S, 1994). Other clinical condition which might affect cardiac output included 
respiratory distress syndrome and sepsis. None of the study subjects who had any major 
change in their clinical condition were included in the data analysis. 
Respiratory support by means of continuous positive airway pressure or intermittent 
positive pressure ventilation might decrease cardiac output by impeding venous retum (Singer 
M et al., 1994; Beydon L et al., 1991). Some of our babies studied required mechanical 
ventilation while others were given supplementary oxygen or breathing air. But their mode of 
ventilation, including the ventilation settings of those who required mechanical ventilation, was 
kept unchanged throughout the study period, and therefore should not affect the results of the 
measurements. 
It is revealed in our study that following red cell transfusion, there is a significant drop 
of cardiac index by an average of 8.7 % within 24 hours after transfusion. Ifthe reduction in 
cardiac index is a reversal of a compensatory response, it should be reflected as changes in 
heart rate as well as stroke volume since compensatory increases in cardiac output would be 
catecholamine driven. However, it is shown in our study that the decrease in cardiac index, 
which is calculated as cardiac output divided by basal surface area (BSA), is merely the result 
of a reduction in stroke volume secondary to decrease in blood flow velocity with no significant 
change in heart rate. The decrease in blood flow velocity without any change in blood pressure 
indicates that there has been an increase in vascular resistance. This is similar to the 
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observations made by Nelle et al. in a group of older and clinically stable preterm infants (Nelle 
M et al, 1994). Nelle et al attributed the decreased blood flow velocity after transfusion to the 
increased systemic flow resistance and blood viscosity. 
Despite the decrease in cardiac output, our group of infants showed a 11.1% post 
transfusion increase in systemic red cell transport which has been shown to be an indicator of 
the status of tissue perfusion (Alverson DC et al., 1988; Nelle M et al., 1994; Guajardo CD, 
Mandelbaum V and Linderkamp 0，1994). Since there is a reduction in cardiac output, the rise 
in systemic red cell transport is a result of a large increase in haematocrit after transfusion. 
II. Oxygen consumption study 
Non-invasive measurements of oxygen consumption have been possible in the clinical 
environment since Neuhof and Wolf improved the technology with the use ofopen circuit method 
in 1978 (Neuhof H and Wolf H, 1978). It has been widely used in metabolic studies in adults 
since then. However, difficulties arise when using indirect calorimetry in low birthweight infants 
mainly due to their very small respiratory volumes. Systems used to measure VO2 and VCO2 
must be able to accurately determine the small differences in gas concentrations. The Deltatrac 
II™ metabolic monitor (Deltatrac II™; Datexy'Instmmentarium, Helsinki, Finland), which is an 
open system indirect calorimetry device, measures VO2 based on the gas dilution principle over 
each minute by diluting mixed expired gas into a known flow of air. This is very compact and 
facilitates measurements of VO2 in both spontaneously breathing and intubated patients 
(Shortland GJ, Fleming PJ and Walter JH, 1992; Weyland W et al., 1994) by the canopy mode 
and the respiratory mode. It allows direct differential measurement of the difference between 
inspired and expired oxygen concentrations. And it has been shown to be accurate in the 
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measurement of oxygen consumption in adult or in infants weighing more than 1000 grams 
(Shortland GJ, Fleming PJ and Walter JH, 1992). 
There are limitations for accurate measurement of VO2. For the canopy mode, a known 
constant of air is drawn through the canopy to diminish the risk of errors by leaks. In premature 
infants, the VO2 and VCO2 are very low and hence sampling flow must be low to prevent 
excessive dilution of expired air. However, the low sampling flow will increase the risk of 
incomplete gas sampling (Shortland GJ, Fleming PJ and Walter JH, 1992). Recently, the 
accuracy of measurement ofVO2 and VCO2 with the use of face mask, head hood and canopy for 
breath sampling in flow-through indirect calorimetry has been compared. The results indicate 
that the face mask is accurate at low flows (3L/min) and is available for accurate measurement of 
VO2 in infants less then 1500 grams (Bauer K et al., 1997). But the investigator has to hold and 
keep the face mask in position by hand on the infant's face during the procedure. 
For the ventilator mode, limitations included loss of expired gas from around the 
endotracheal tube. Although cuffed endotracheal tube can effectively abolish airleaks around the 
endotracheal tube, it is not commonly used in infants because of the possibility of inducing 
tracheal injury and postextubation croup (Uejima T, 1989). Chwals et al, however, demonstrated 
that VO2 determined by indirect calormetry may be reliable in infants and children with the use of 
a noncuffed endotracheal tube if no audible airleak is detected (Chwals WJ, Lally KP and 
Woolley MM, 1992). However, there is no data available in premature babies. 
Once anaemia occurs, compensatory mechanism such as an increase in cardiac output 
will be activated to maintain adequate oxygen supply. Increased cardiac output is associated with 
an increase in oxygen consumption and this can be corrected by transfusion (Chessex P et al., 
1981). However, infant's ability to compensate for hypoxia with an increased cardiac output is 
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limited (Romero TE and Friedman WF, 1979). When anaemia becomes severer, a decrease in 
oxygen consumption (Lachance C et al., 1994) and slow weight gain (Stockman JA III and Clark 
DA, 1984) will occur in order to adapt to the level of anaemia; in this case, an increase in oxygen 
consumption after transfusion would be expected. 
In the present study, although VO2 seems to decrease after transfusion as shown in table 
5, it has not reached statistical significance. This may be attributed to the small case number. 
Although premature babies who required red blood transfusion were not uncommon in our unit, 
there was major difficulty in recuiting cases. Namely, most of the babies who required blood 
transfiision were ventilated. Efforts were made for the accurate measurement of VO2 on those 
ventilated babies but were in vain. The ventilators used in our unit (bifant Star) were not suitable 
for accurate measurement since there was a mixing of expired gas from the infants and from the 
purging system at the expiratory outlet that might result in considerable errors due to dilution of 
the expired gas. Moreover, the airleakage around the endotracheal tube was also difficult to 
avoid. The high F1O2 was another deterrent for the accurate measurement of VO2 As a 
consequence, only 10 infants who were breathing spontaneously were enrolled during the 5 
months' study period. 
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Section 6 Conclusion 
We conclude that there is a significant drop in cardiac index and an improvement in 
systemic red cell transport within 24 hours after transfusion in premature babies. 
There is no significant change in oxygen consumption after red cell transfusion in our 
group of premature infants. However, this may be attributed to the small case number included 
in the analysis. 
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Section 7 Future Direction 
This study has demonstrated the acute effect of red blood cell transfusion on left 
ventricular output and on oxygen consumption in premature babies. 
The reduction in cardiac output after transfusion may not be a reversed compensatory 
response since there is no significant change in heart rate after transfusion. The systemic red cell 
transport increased after transfusion and indicates that blood transfusion may improve the 
oxygenation of the babies in the short term. However, whether sick preterm infants would benefit 
from blood transfusion in the long term is not known. Follow up studies may be valuable. 
In the oxygen consumption study, the small case number is a major difficulty. It was 
very difficult to recruit adequate number of premature babies into the study with stable clinical 
conditions and who did not require ventilation support. However, if the technical problem of 
measuring oxygen consumption in ventilated babies can be solved, it is worthwhile to carry on 
the study again. 
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Section 8 Tables and Figures 
Table 1. Characteristics of 57 premature babies who received RBC transfusion 
Parameters Mean SD Range 
‘••••••••-^--••^^-••••••••-••-••-^*-••••^^••••-••-^^••-••••^*•"•*•---^•• ‘^*•*••••-*•*•----^••*•^*•*"•*•*•*•••*••••••"-*•*•^••*•*•••*•••••••^---*•^•••^"•••••---•••^«"«"、》>">~«~»-~«>«>«>\»>»--—>l»w«_V«>«»l»>^^«>«^H、、《_«>«^«_» ‘^、《_>_«_«^« ‘^____>_K»_<KM~l __ 
Gestational age (wks) 28.8 2.5 23.1 - J i l 
Postnatal age (days) 14.0 9.0 1 - 29 
Weight (grams) 1206 297 810 - 1900 
Body surface area (m^ 0.109 0.019 0.08 - 0.17 
, v , w o n 0 . v x » « M 0 0 0 < x i . . i i . . i • • •      
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Table 2 . Haemodynamic Data before and 24 hours after transfusion. 
(Values are represents as the mean (SD)) 
Before 24 hrs after A change P value 
Transfusion Transfusion 
、•_、•_ ^  «•>«•«• «A ^ ^^ «.«,、•_•_、•_ ^«.^  - ^ •_ •»- ^-一、••-••« ^¾^*.〜-〜》•、、〜»«• -�•>、••" »^一 «•、-»"一 -»«•••»—• »^ «^-*-^  ^ **«^ M.».^ »«. «•、••«、《、«•»«•�% -、、《•««, - « , «•«•«•«• «•«•••、《 〜、、〜《 _—^ « _、‘•_« _〜、 ^ ^ s >_«_«_ 〜 _ _ « _ « _ » _ « _〜〜《、 _ _、 _ _〜认 
HCT (o/o) 34.5 (4.2) 41.7 (4.2) 7.2 (5.5) o7oo5T— 
HR(beatAnin) 154.95 (15.78) 157.02(13.27) 2.07 (14.21) 0.3 
SBP (mmHg) 59.69 (11.17) 61.61 (9.48) 1.47 (11.03) 0.3 
DBP (mmHg) 8.41 (1.18) 9.08 (1.27) 2.84(10.49) 0.1 
F1O2 (%) 26.12 (15.51) 25.46(13.47) 0.654 (2.4) 0.2 
VTI(cm) 0.07 (0.02) 0.06 (0.02) -0.007(0.016) 0.002 
SV(ml/beat) 1.6(0.6) 1.5(0.4) 0.2(0.4) 0.006 
C0 (l/min) 0.25 (0.08) 0.23 (0.07) -0.02(0.06) 0.016 
CI(l/min/M^) 2.29 (0.62) 2.10(0.63) -0.20(0.64) 0.023 
Systemic red cell transport 0.09(0.03) 0.10 (0.03) 0.01(0.02) 0 00001 
(COxHCT) 
LVET 0.181 (0.027) 0.172 (0.021) -0.009 (0.028) 0.021 
EF (%) 59.4(8.1) 61.5 (9.8) 2.06 (7.98) 0.1 
FS(o/o) 29.1 (5.4) 30.6 (6.9) 1.48 (5.53) 0.1 
HCT: Haematocrit; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FA： 
Concentration of inspired oxygen; SV: Stroke volume; CO: Cardiac output; CI: Cardiac index’； VTI: 
Velocity time integral; LVET: Left ventricular ejection time; EF: Ejection fraction; FS: Fraction shortening 
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Table 3. Estimates of association between cardiac index and haematocrit using mixed-
effects regression model 
Variables Coefficient Standard Error 95% CI p-value 
—乐;^[.“顶.- -6.030 0"008 (：0；0467'5"'014)……6".0602  
Sex' -0.378 0.143 (-0.664, -0.092) 0.0081 
‘Reference category ismale ~~~~~~-
P.S. gestational age, postnatal age, SBP, DBP were insignificant at 5% level 
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Table 4. Characteristics of 10 infants in the study of transfusion effect on oxygen 
consumption. 
< w o o c w c w o c * K * * w x w x w * w c w w x w c w * w x K W X w c w w o t v * x w x * w r t x w c * w o c w c w c w w * w x w c w w x w c v * * f c > * w c * x w w w * * w t x * v w > x v o c w w > x v w o r t x > x w w ^ 
Mean (SD) Range 
~^stational ^ e (weeks) 29.6 (4.97^ 17.1 -34.4 
Postnatal age (days) 33.6 (24.8) 5 - 89 
Weight (grams) 1590 (467) 1045 -2710 
RBC transfused (ml/kg) 14.99 (7.38) 14.35 - 20.3 
n ^ C R e T W o o d c e H 
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Table 5. Vital signs and metabolic data before, one hour after, and 24 hours after 
transfusion. (Values are presented as mean(SD)) 
»、、、>、、、、、y*、>、、w»w»、、、w>、、v»>x»wfc、、、~»wwv»、、、w»、、、、Tf«nntTrv»Ti、、T«Tn>、、Tfwr>y»、、、、*rw»f»、、、、w»w>、、、、"^"^、、’、"《"»、-^>^-.^^-.^^^^^^^^^^w.-.->>^.. 一、^、、、、、^_^、、一^、•>•»、•»、、、、-[ .^ [ _ L、、、、、、、、、、、、_^、、、__^、^^^^^、~«~«、、w>、、、、 
1 hour before 24 hrs after A change P value 
transfusion transfusion 
…只^^两 b""322 (6"oS) 03^(a059) 0"06i O.T  
HR (bpm) 149.9 (8.565) 138.2 (16.53) -11.667 0.042 
RR (per min) 53.63 (14.3) 55.75 (20.32) 2.125 0.9 
SBP (mmHg) 66.78 (7.396) 67.167(12.073) 1.667 0.9 
DBP (mmHg) 39.9 (4.045) 40.33 (10.463) 0.667 0.9 
VCO2(ml/min) 10.79 (4.34) 9.42 (2.81) -1.367 0.1 
VO2 (ml/min) 10.15 (4.325) 9.42 (3.16) -0.731 0.4 
RQ 1.028 (0.364) 1.01 (0.088) -0.019 0.98 
EE (kcal/day) 76.75 (33.25) 71.25 (21.75) -5.507 0.4 
"i3SFTissfiissssrMnsi^^n^nKE^i^^i^^r7s^^f^gp^"55;;^;j"^;^3"j^^^^^j;;:j^^^g^r;g^toiic 
blood pressure; VO2: Oxygen consumption; VCO2: Carbon dioxide production; RQ: Respiratory quotient-
EE: Energy expenditure ‘ 
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